Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
International Journal of COPD, 07/01/09
Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet - Early Online Publication, 11/18/09
Coenzyme Q10; an adjunctive therapy for congestive heart failure?
New Zealand Medical Journal, 11/04/09
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitamin D and cardiovascular disease
Current Atherosclerosis Reports, 11/12/09
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy , 11/16/09
Cardiac troponin-I as a screening tool for myocarditis in children hospitalized for viral infection
Acta Pediatrica, 11/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


